A pharmacy dispenses on a prior authorization the PBM's own system approved, and the point-of-sale confirmation reads clean. Months later, the same PBM's audit team reopens that file and questions the approval it granted, often citing incomplete clinical documentation held by the prescriber rather than any error at the pharmacy counter. The pharmacy ends up defending a decision it did not make, using a record it does not fully possess. When the finding survives, the recoupment can reach every claim filled under that authorization, not just the single fill named in the audit letter.
How Prior Authorization Approvals Get Reopened
A PBM audit does not treat a prior authorization as closed once the claim adjudicates and pays. Audit teams sample dispensed claims after the fact and re-examine the PA record for the defects that would have blocked the fill in the first place: an authorization not properly obtained, a submission that does not match the underlying prescription, or pharmacy involvement in the PA process beyond what the plan's manual allows. Healthcare counsel at Frier Levitt has tracked PBM audit teams citing approved prior authorizations as “not properly obtained or authorized” or as containing unsupported information, even when the same PBM issued the approval and paid the claim. The posture is strict: a deviation from the provider manual can support a finding regardless of whether the prescription itself was clinically appropriate.
The Documentation Gap Between Pharmacy and Prescriber
What a pharmacy can retain from a prior authorization is narrow by design: the approval confirmation, an authorization or reference number, the drug, strength, quantity, and diagnosis approved, and the effective date range. The clinical basis for that approval, the chart notes, lab values, and prior therapy history that justified it, sits in the prescriber's own patient record, not the pharmacy's file, and the pharmacy has no lawful way to obtain it before dispensing. When a PBM audit later demands the clinical support behind the PA, the pharmacy is asked to produce a record it never had. A prescriber attestation confirming what was submitted, and by whom, is often the strongest substitute available. Frier Levitt has recommended pharmacies assemble that kind of supporting documentation proactively, rather than for the first time after an audit letter arrives.
Where the Audit Shifts the Burden
PBM audits built on prior authorizations turn on proof, not existence. The pharmacy has to show, months or years later, that the drug, strength, quantity, and diagnosis approved match what was billed, and that its role in obtaining the authorization stayed within what the plan's manual allows. A mismatch on any of those points becomes an independent finding, apart from any question about medical necessity. Frier Levitt has documented PBM audit teams discounting prescriber-supplied documentation outright, treating supporting statements from the prescriber's office as insufficient and continuing to press the finding until counsel becomes involved. Left unresolved, a documentation finding on a single prior authorization can widen into a broader recoupment demand and, in repeat cases, into network termination proceedings. A timely audit appeal preserves the argument that confirming the clinical basis behind a PBM-issued approval was never the pharmacy's obligation to begin with, a defense that accepting the finding forfeits.
An approved prior authorization is a snapshot, and the clinical documentation behind it is what the pharmacy answers for when the PBM's own audit team reopens the file months or years later.
Why Early Legal Counsel Is Critical
It is critical that pharmacies promptly retain experienced healthcare defense counsel upon receiving a PBM audit notice or recoupment demand that turns on prior authorization documentation. Early legal intervention can protect the pharmacy's rights, ensure the response to the PBM addresses each finding on its documentary merits, avoid inadvertent admissions, preserve every available defense, and allow counsel to communicate with the auditor on the pharmacy's behalf. Delaying legal representation can significantly affect the outcome of the audit and expose the pharmacy to unnecessary risk.
How Health Law Alliance Can Help
Health Law Alliance defends pharmacies against PBM audits, recoupment demands, and network terminations across OptumRx, CVS Caremark, Express Scripts, Humana, and Prime. Our team includes a former federal prosecutor and a former senior executive from a major pharmacy benefit manager, background that shapes how a prior-authorization-based finding gets tested and where it is vulnerable to challenge. If your pharmacy is facing an audit built on a prior authorization the PBM already approved, contact us for a free, confidential consultation.
